Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine if giving a larger amount of DHA than currently included in some prenatal supplements can reduce early preterm birth (birth before 34 weeks of pregnancy).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Kansas Medical Center
Collaborators
NCT05787509 · Preterm Birth
NCT07424846 · Preterm Birth, Low Birthweight Neonate, and more
NCT07192393 · Prematurity; Extreme, Prematurity; Decision Support, and more
NCT05966649 · Preterm Spontaneous Labor With Preterm Delivery, Preterm Birth, and more
NCT06396078 · Preterm Premature Rupture of Membrane, Pregnancy, High Risk, and more
University of Kansas Medical Center
Kansas City, Kansas
University of Cincinnati
Cincinnati, Ohio
Ohio State University
Columbus, Ohio
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions